Methyl-β-cyclodextrin potentiates the BITC-induced anti-cancer effect through modulation of the Akt phosphorylation in human colorectal cancer cells

Qifu Yang, Miku Miyagawa, Xiaoyang Liu, Beiwei Zhu, Shintaro Munemasa, Toshiyuki Nakamura, Yoshiyuki Murata, Yoshimasa Nakamura

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Methyl-β-cyclodextrin (MβCD) is an effective agent for the removal of plasma membrane cholesterol. In this study, we investigated the modulating effects of MβCD on the antiproliferation induced by benzyl isothiocyanate (BITC), an ITC compound mainly derived from papaya seeds. We confirmed that MβCD dose-dependently increased the cholesterol level in the medium, possibly through its removal from the plasma membrane of human colorectal cancer cells. The pretreatment with a non-toxic concentration (2.5 mM) of MβCD significantly enhanced the BITC-induced cytotoxicity and apoptosis induction, which was counteracted by the cholesterol supplementation. Although BITC activated the phosphoinositide 3-kinase (PI3K)/Akt pathway, MβCD dose-dependently inhibited the phosphorylation level of Akt. On the contrary, the treatment of MβCD enhanced the phosphorylation of mitogen activated protein kinases, but did not potentiate their BITC-induced phosphorylation. These results suggested that MβCD might potentiate the BITC-induced anti-cancer by cholesterol depletion and thus inhibition of the PI3K/Akt-dependent survival pathway.

Original languageEnglish
Pages (from-to)2158-2167
Number of pages10
JournalBioscience, Biotechnology and Biochemistry
Volume82
Issue number12
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Phosphorylation
Cyclodextrins
Colorectal Neoplasms
Cells
Modulation
Cholesterol
Neoplasms
1-Phosphatidylinositol 4-Kinase
Cell membranes
Phosphatidylinositols
Phosphotransferases
Cell Membrane
Carica
Cytotoxicity
benzyl isothiocyanate
Mitogen-Activated Protein Kinases
Seed
Seeds
Apoptosis
Survival

Keywords

  • Akt
  • Apoptosis
  • Benzyl isothiocyanate
  • Cholesterol
  • Methyl-β-cyclodextrin

ASJC Scopus subject areas

  • Biotechnology
  • Analytical Chemistry
  • Biochemistry
  • Applied Microbiology and Biotechnology
  • Molecular Biology
  • Organic Chemistry

Cite this

@article{224631e76194484f80fa48806507686f,
title = "Methyl-β-cyclodextrin potentiates the BITC-induced anti-cancer effect through modulation of the Akt phosphorylation in human colorectal cancer cells",
abstract = "Methyl-β-cyclodextrin (MβCD) is an effective agent for the removal of plasma membrane cholesterol. In this study, we investigated the modulating effects of MβCD on the antiproliferation induced by benzyl isothiocyanate (BITC), an ITC compound mainly derived from papaya seeds. We confirmed that MβCD dose-dependently increased the cholesterol level in the medium, possibly through its removal from the plasma membrane of human colorectal cancer cells. The pretreatment with a non-toxic concentration (2.5 mM) of MβCD significantly enhanced the BITC-induced cytotoxicity and apoptosis induction, which was counteracted by the cholesterol supplementation. Although BITC activated the phosphoinositide 3-kinase (PI3K)/Akt pathway, MβCD dose-dependently inhibited the phosphorylation level of Akt. On the contrary, the treatment of MβCD enhanced the phosphorylation of mitogen activated protein kinases, but did not potentiate their BITC-induced phosphorylation. These results suggested that MβCD might potentiate the BITC-induced anti-cancer by cholesterol depletion and thus inhibition of the PI3K/Akt-dependent survival pathway.",
keywords = "Akt, Apoptosis, Benzyl isothiocyanate, Cholesterol, Methyl-β-cyclodextrin",
author = "Qifu Yang and Miku Miyagawa and Xiaoyang Liu and Beiwei Zhu and Shintaro Munemasa and Toshiyuki Nakamura and Yoshiyuki Murata and Yoshimasa Nakamura",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/09168451.2018.1514249",
language = "English",
volume = "82",
pages = "2158--2167",
journal = "Bioscience, Biotechnology and Biochemistry",
issn = "0916-8451",
publisher = "Japan Society for Bioscience Biotechnology and Agrochemistry",
number = "12",

}

TY - JOUR

T1 - Methyl-β-cyclodextrin potentiates the BITC-induced anti-cancer effect through modulation of the Akt phosphorylation in human colorectal cancer cells

AU - Yang, Qifu

AU - Miyagawa, Miku

AU - Liu, Xiaoyang

AU - Zhu, Beiwei

AU - Munemasa, Shintaro

AU - Nakamura, Toshiyuki

AU - Murata, Yoshiyuki

AU - Nakamura, Yoshimasa

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Methyl-β-cyclodextrin (MβCD) is an effective agent for the removal of plasma membrane cholesterol. In this study, we investigated the modulating effects of MβCD on the antiproliferation induced by benzyl isothiocyanate (BITC), an ITC compound mainly derived from papaya seeds. We confirmed that MβCD dose-dependently increased the cholesterol level in the medium, possibly through its removal from the plasma membrane of human colorectal cancer cells. The pretreatment with a non-toxic concentration (2.5 mM) of MβCD significantly enhanced the BITC-induced cytotoxicity and apoptosis induction, which was counteracted by the cholesterol supplementation. Although BITC activated the phosphoinositide 3-kinase (PI3K)/Akt pathway, MβCD dose-dependently inhibited the phosphorylation level of Akt. On the contrary, the treatment of MβCD enhanced the phosphorylation of mitogen activated protein kinases, but did not potentiate their BITC-induced phosphorylation. These results suggested that MβCD might potentiate the BITC-induced anti-cancer by cholesterol depletion and thus inhibition of the PI3K/Akt-dependent survival pathway.

AB - Methyl-β-cyclodextrin (MβCD) is an effective agent for the removal of plasma membrane cholesterol. In this study, we investigated the modulating effects of MβCD on the antiproliferation induced by benzyl isothiocyanate (BITC), an ITC compound mainly derived from papaya seeds. We confirmed that MβCD dose-dependently increased the cholesterol level in the medium, possibly through its removal from the plasma membrane of human colorectal cancer cells. The pretreatment with a non-toxic concentration (2.5 mM) of MβCD significantly enhanced the BITC-induced cytotoxicity and apoptosis induction, which was counteracted by the cholesterol supplementation. Although BITC activated the phosphoinositide 3-kinase (PI3K)/Akt pathway, MβCD dose-dependently inhibited the phosphorylation level of Akt. On the contrary, the treatment of MβCD enhanced the phosphorylation of mitogen activated protein kinases, but did not potentiate their BITC-induced phosphorylation. These results suggested that MβCD might potentiate the BITC-induced anti-cancer by cholesterol depletion and thus inhibition of the PI3K/Akt-dependent survival pathway.

KW - Akt

KW - Apoptosis

KW - Benzyl isothiocyanate

KW - Cholesterol

KW - Methyl-β-cyclodextrin

UR - http://www.scopus.com/inward/record.url?scp=85056300506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056300506&partnerID=8YFLogxK

U2 - 10.1080/09168451.2018.1514249

DO - 10.1080/09168451.2018.1514249

M3 - Article

C2 - 30200817

AN - SCOPUS:85056300506

VL - 82

SP - 2158

EP - 2167

JO - Bioscience, Biotechnology and Biochemistry

JF - Bioscience, Biotechnology and Biochemistry

SN - 0916-8451

IS - 12

ER -